December 13, 2022
The Right Time For Chip Export Controls
On Oct. 7, the U.S.-China tech competition heated up dramatically when the Biden administration imposed wide-ranging semiconductor-related export controls on China. While there has been plenty of discussion of the extraordinary scope and scale of the controls, less attention has been paid to their timing.
Why did the Biden administration choose to impose these controls now? And why did the Biden team act when it did? Did the United States squander future leverage over China’s artificial intelligence (AI) and weapons development efforts? What was the trade-off considered between acting unilaterally now and spending more time to get allies on board? The question of “Why now?” is an important one, because it has direct bearing on whether these policies will be both effective (that is, by preventing the items and services from going to China) and not counterproductive (that is, by not helping foreign competitors of U.S. companies affected).
Convincing allies to follow suit on manufacturing equipment restrictions is imperative, as controls will be broader and have greater impact when executed in tandem with the Netherlands and Japan.
The Department of Commerce’s Bureau of Industry and Security (BIS) published a rule with five main parts. One part banned any entity or individual from supplying leading-edge graphics processing units (GPUs)—a type of integrated circuit that accelerates the creation of images—and electronics containing them to any other entity or individual in China. These controls were imposed because GPU chips play an important role in the development and use of artificial intelligence applications, particularly the deep learning methods that are the main driver of the current AI boom. This ban applies to all foreign-made GPUs as a result of a modified extraterritorial jurisdictional rule called the foreign direct product rule, or FDPR for short. The new FDPR subjects any such chip made directly from American technology or software, or produced, even in part, from U.S.-made semiconductor production equipment to U.S. jurisdiction.
Read the full article from Lawfare.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko